BIND Therapeutics (BIND) Names Jonathan Yingling Chief Scientific Officer
Tweet Send to a Friend
BIND Therapeutics, Inc. (NASDAQ: BIND) announced the appointment of Jonathan Yingling, Ph.D., as Chief Scientific Officer. In this position, Dr ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
